Original Research

Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-eclampsia: A prospective Cohort Study

DOI https://doi.org/10.70302/jpsim.v5i4.2473
Received: 16 Feb 2024 Accepted: 02 Nov 2024 Published Online: 09 Dec 2024

Abstract

Objectives

To assess the connotation among elevated serum uric acid (SUA) levels and adverse fetal outcomes in women with pre-eclampsia.

Methods

This Prospective, cohort study was conducted in the Department of Obstetrics & Gynecology, Fauji Foundation Hospital, Rawalpindi. Ethical approval was granted by the ERC of the hospital. A total of 60 women (30 exposed and 30 unexposed) with of age 18-40 years were included. Patients with already taking medications for hyperuricemia, chronic hypertension, CRF and severe systemic illness like 2 uncontrolled diabetes mellitus, heart diseases were excluded. Group A (exposed) included the females with serum uric acid levels ≥6 mg/dl on presentation while Group B (unexposed) included pregnant females with serum uric acid levels. Data was analyzed using SPSS-25.0

Results

The study results indicated that 50.0% of women with serum uric acid level of ≥6 mg/dl and pre-eclampsia experienced low birth weight, whereas only 26.67% of women having a SUA level of <600 mg/dl and preeclampsia had this outcome. Additionally, 40.0% of women with pre-eclampsia and high serum uric acid levels had intrauterine growth retardation, compared to 6.67% of those with lower serum uric acid levels. NICU admission was also more common in women with serum uric acid ≥6 mg/dl (23.33%) and pre-eclampsia as compared to those with <600 mg/dl (6.67%). These findings, with a p-value of <0.05 and a relative risk of >1, signify a significant and positive association between elevated serum uric acid levels and adverse outcomes for both the fetus and the mother.

Conclusion

This study concluded that there is a positive association between high serum uric acid levels and adverse feto-maternal outcome.

Keywords
Preeclampsia Uric acid Feto-maternal outcome

How to Cite This Article

Mujeeb A, Tabassum H, Masoud A, Ahmed M, Bokhari NA, Fatima A. Serum Uric Acid as a Predictor of Perinatal Outcome in Women with Pre-eclampsia: A prospective Cohort Study. J Pak Soc Intern Med. 2024;5(4):723–728. doi:10.70302/jpsim.v5i4.2473

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Lean SC, Derricott H, Jones RL, Heazell AE. Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis. PloS one. 2017 Oct 17;12(10):e0186287.
  2. Saeed S, Jamal A, Rafiq FA, Rafiq F, Jamal A. Frequency of hypocalcemia in women with preeclampsia at a tertiary care hospital. Pakistan J Med Heal Sci. 2017 Apr 1;11(2):773-6.
  3. Le TM, Nguyen LH, Phan NL, Le DD, Nguyen HVQ, Truong VQ, et al. Maternal serum uric acid concentration and pregnancy outcomes in women with preeclampsia/eclampsia. Int J Gynecol Obstet. 2019;144:21–6
  4. Aelie R, Jun CN, Sook KY, Young LE. Predictive value of serum uric acid levels for adverse perinatal outcomes in preeclampsia. Med. 2019;98(18):e15462.
  5. Kanagal DV, Rajesh A, Rao K, Devi UH, Shetty H, Kumari S, et al. Levels of serum calcium and magnesium in pre-eclamptic and normal pregnancy: a study from Coastal India. J Clin Diagn Res. 2014;8(7):OC01–OC04.
  6. Essiben F, Itembe O, Foumane P, Nguefack MT, Eko FE. Blood uric acid level as a marker of increased risk of eclampsia in severe pre‐eclamptic patients: A cross‐ sectional study in two tertiary hospitals of Yaoundé, Cameroon. Health Sci Dis. 2016;17:7–11.
  7. Alzuabidi ZFM. The role of uric acid in predicting preeclampsia. Women. J Chem Pharmaceut Res. 2016;8(4):1175-79.
  8. Reynolds C, Mabie WC, Sibai BM. "Pre-eclampsia". Pregnancy - Hypertensive Disorders. Arm Med Network. 2006; Retrieved 2006-11-23.
  9. Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol. 2009;113(6):1217-24.
  10. Alzuabidi ZFM. The role of uric acid in predicting preeclampsia. Women. J Chem Pharmaceut Res. 2016;8(4):1175-79.
  11. Kumar N, Singh AK. Maternal serum uric acid as a predictor of severity of hypertensive disorders of pregnancy: a prospective cohort study. Curr Hypertens Rev. 2019;15(2):154–60.
  12. Toshniwal S, Lamba AR. Serum uric acid as marker of severity of pre-eclampsia. Int J Reprod Contracept Obstet Gynecol. 2017;6(11):4915-7.
  13. Nair A, Savitha C. Estimation of serum uric acid as an indicator of severity of preeclampsia and perinatal outcome. J Obst Gynecol India. 2017;67(2):109-18.
  14. Shand A, Nassar N, Von Dadelszen P, Innis S, Green T. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for preeclampsia. BJOG. 2010;117(13):
  15. Chappell LC, Cluver CA, Tong S. Pre-eclampsia. The Lancet. 2021 Jul 24;398(10297):341-54.
  16. Martin AC, Brown MA. Could uric acid have a pathogenic role inpreeclampsia? Nat Rev Nephrol 2010;6:744–8.
  17. Bainbridge SA, Deng JS, Roberts JM. Increased xanthine oxidase inthe skin of pre-eclamptic women. Reprod Sci 2009;16:468–78
  18. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia.Am J Pathol 2000;156:321–31
  19. Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor inpreeclampsia. Placenta 2008;22:S67–72
  20. Feig DI, Kang D-H, Johnson RJ. Uric acid and cardiovascular risk.N Engl J Med 2008;359:1811–21

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2024 Journal of Pakistan Society of Internal Medicine.